Safety Must Be Prioritized In Drugs for Cancer

Despite the fact that the number of diagnosed cases of malignant mesothelioma are expected to rise in the next decades, there has been little real progress in available treatments, and the chemotherapy drug used to treat the disease is the same one that has been used for the last several  years. Though there is a [...]

By | 2018-05-23T16:46:08+00:00 May 16th, 2018|Press|Comments Off on Safety Must Be Prioritized In Drugs for Cancer

Professor Ruth Roberts Receives International Award

Professor Ruth Roberts – co-founder and director of nonclinical safety company, ApconiX based at Alderley Park, Cheshire – is the first non-US-based scientist to receive a prestigious international award for professionals specialising in drug and chemical safety. She is only the tenth person to receive the US-based Society of Toxicology (SOT) Founders Award, presented for “outstanding leadership in fostering the role of [...]

By | 2018-06-20T16:25:53+00:00 December 15th, 2017|Press|Comments Off on Professor Ruth Roberts Receives International Award

Learning from Failure

Cardiovascular toxicity often hinders success – are companies picking the wrong compounds? Prolific novelist and academic CS Lewis once said, “Failures are finger posts on the road to achievement.” (Given pharma’s drug failure rate, the road ahead must truly be paved in gold.) When it comes to drug safety failure, toxicity – especially to the [...]

By | 2018-06-20T16:05:32+00:00 November 2nd, 2017|Ion Channels, Press|Comments Off on Learning from Failure

Sygnature Discovery Forms a Strategic Alliance with ApconiX

02 October 2017 – Nottingham and Alderley Park, UK – Sygnature Discovery, the UK's largest independent provider of integrated drug discovery resource and expertise, has announced it is to work in partnership with ApconiX, experts in non-clinical safety strategies and ion channel screening, to offer a broader range of drug discovery services. Dr Paul Clewlow, [...]

By | 2018-06-06T14:50:03+00:00 October 3rd, 2017|Press|Comments Off on Sygnature Discovery Forms a Strategic Alliance with ApconiX

ApconiX Announce Their Alliance with PhysioStim.

The European Centre of Excellence for preclinical cardiovascular electrophysiology. The ApconiX team is pleased to announce their alliance with PhysioStim to create a new Centre of Excellence dedicated to cardiac safety studies. Both companies team up to offer a complete range of services in nonclinical cardiovascular electrophysiology. ApconiX, based at Alderley Park in the U.K. [...]

By | 2018-06-20T16:06:07+00:00 September 21st, 2017|Ion Channels, Press|Comments Off on ApconiX Announce Their Alliance with PhysioStim.

APTrans signs agreement with Evgen Pharma to support the development of the lead product, SFX-01.  

In February, APTrans signed a service agreement with Evgen Pharma to provide support to their lead program, SFX-01. Evgen Pharma is a clinical stage drug development company with projects in breast cancer and subarachnoid haemorrhage. APTrans is a consortium of companies based at the BioHub at Alderley Park, formed by ApconiX, Aptus Clinical and Seda [...]

By | 2018-06-06T14:50:53+00:00 March 8th, 2017|Press|Comments Off on APTrans signs agreement with Evgen Pharma to support the development of the lead product, SFX-01.  

ApconiX New Year Message 2017!

As we get ready for a busy and exciting 2017, it’s a good time to reflect on ApconiX’s first full year in business and share some notable highlights. In 2016 we were joined by several additional preclinical experts including Dr Guy Healing, Dr Damian Deavall, Dr Jane Barber, Dr Mike O’Donovan and Dr Peter Ballard [...]

By | 2018-06-06T14:51:39+00:00 January 6th, 2017|Press|Comments Off on ApconiX New Year Message 2017!

ApconiX Official Lab Opening!

It was a pleasure to welcome all our colleagues and collaborators to the official opening of the new ApconiX lab at Alderley Park March 1st 2016.  Professor Graham Boulnois (Chair of the Drug Discovery Medicines Catapult) cut the red ribbon, surrounded by well-wishers and the 3 ApconiX co-directors and co-founders, Richard Knight, Ruth Roberts and [...]

By | 2018-06-06T15:00:15+00:00 March 8th, 2016|Press|Comments Off on ApconiX Official Lab Opening!

ApconiX on the BBC News!

ApconiX was featured November 19th 2015 in a BBC News NorthWest item as one of the success stories of the Northern Power House (click here for video). BBC political correspondent Arif Ansari was interested to hear how we assembled a team of the best expert science professionals all of whom want to stay in the North [...]

By | 2018-05-30T16:55:46+00:00 November 23rd, 2015|Press|Comments Off on ApconiX on the BBC News!